The cannabis plant contains dozens of cannabinoids, with each possessing its own characteristics and potential wellness benefits. Cannabidiol (CBD) is one of the most popular cannabinoids among consumers and patients, being infused into a wide variety of products these days, including edibles. According to a recent report out of France, the European nation may be in the process of banning CBD edibles.

“France will ban the sale of cannabidiol (CBD) edibles from May 15, while still allowing it to be sold to be smoked, AFP learnt from several sources on Thursday.” reports France 24. “Contacted by AFP, the Directorate General for Food (DGAL) did not respond immediately, but the government is expected to issue a statement in the coming days, the Ministry of Agriculture said.”

According to an industry expert referenced by France 24 in its local coverage, “CBD edibles account for about 40 percent of sales in the specialised shops that have cropped up in cities and towns across France.”

Only time will tell if an official ban is announced and implemented in France in the coming days, but if it does, legal challenges are virtually guaranteed to occur, although it is unclear whether those potential legal challenges will succeed or not.

France is one of the largest cannabis markets in Europe, albeit almost entirely unregulated. An estimated 99.7% of France’s cannabis industry remains unregulated, resulting in a lot of profit potential going untapped by entrepreneurs and investors.

Lawmakers and regulators in France have worked in recent years to craft a more modernized medical cannabis model, and with a national population of over 68 million people, a legalized cannabis industry in France has the potential to become one of the largest on the planet.

According to the European Union Drugs Agency’s 2025 report, France is home to the highest lifetime cannabis usage rate by adults in the European Union. Over half of adults in France (50.4%) report having used cannabis at least once during their lifetime. For context, the next closest nations on the report are Spain at 43.7% and Denmark at 37.6%.

A previous market analysis conducted by Beau Whitney of Whitney Economics found that France is ranked in the top three European markets for cannabis, with an overall potential market value of $8.3 billion, and that boosting medical cannabis access in France could reduce health care system expenditures by nearly $1 billion.

“There are many opportunities for investment into the French cannabis and wellness markets. Keep in mind, as a medical grower/supplier in France, one has access to the entire EU market. Getting a foot in the door in France could prove to be quite lucrative in the future.” Beau Whitney stated.

A separate study by an economic advisory board within the nation’s prime minister’s office determined that the French government spends roughly €570m annually on cannabis prohibition enforcement. The study recommended that France adopt adult-use cannabis legalization and launch a regulated recreational industry.

Emmanuelle Auriol, a professor at the Toulouse School of Economics who authored the study’s report and findings, estimated that such a policy change could create as many as 80,000 new jobs and generate €2.8bn in taxes annually.